Joint Stock Co Pharmstandard Public, 10% Owner at ARGOS THERAPEUTICS INC (ARGS), bought 21,000 shares at $4.73 ($99K) on 2016-10-07, disclosed to the SEC on 2016-10-13.
Open-market purchase of $99k ARGS by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Negative factors outweigh the positive ones.
| Filing → |
| ARGS | BUY | 2016-09-21 | $420K | — | Filing → |
| ARGS | BUY | 2016-09-20 | $501K | — | Filing → |
| ARGS | BUY | 2016-08-25 | $305K | — | Filing → |